Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study.
Januschowski K, Dimopoulos S, Szurman P, Feltgen N, Spitzer B, Pielen A, Rehak M, Spital G; Bevacizumab Study Group Venous Occlusion; Meyer CH, Szurman GB. Januschowski K, et al. Among authors: rehak m. Acta Ophthalmol. 2015 Aug;93(5):e400-e402. doi: 10.1111/aos.12600. Epub 2015 Jan 25. Acta Ophthalmol. 2015. PMID: 25619682 Free article. No abstract available.
Retinal vein thrombosis: pathogenesis and management.
Rehak M, Wiedemann P. Rehak M, et al. J Thromb Haemost. 2010 Sep;8(9):1886-94. doi: 10.1111/j.1538-7836.2010.03909.x. J Thromb Haemost. 2010. PMID: 20492457 Free article. Review.
Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion.
Jaissle GB, Szurman P, Feltgen N, Spitzer B, Pielen A, Rehak M, Spital G, Heimann H, Meyer CH; Retinal Vein Occlusion Study Group. Jaissle GB, et al. Among authors: rehak m. Graefes Arch Clin Exp Ophthalmol. 2011 Feb;249(2):183-92. doi: 10.1007/s00417-010-1470-2. Epub 2010 Aug 18. Graefes Arch Clin Exp Ophthalmol. 2011. PMID: 21337042 Free PMC article.
Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicentre study.
Szurman GB, Januschowski K, Szurman P, Feltgen N, Spitzer B, Pielen A, Rehak M, Spital G, Dimopoulos S; Bevacizumab Study Group Venous Occlusion; Meyer CH. Szurman GB, et al. Among authors: rehak m. Acta Ophthalmol. 2017 May;95(3):e245-e246. doi: 10.1111/aos.12976. Epub 2016 Feb 1. Acta Ophthalmol. 2017. PMID: 26833721 Free article. No abstract available.
Clinical Efficacy and Safety of Ranibizumab Versus Dexamethasone for Central Retinal Vein Occlusion (COMRADE C): A European Label Study.
Hoerauf H, Feltgen N, Weiss C, Paulus EM, Schmitz-Valckenberg S, Pielen A, Puri P, Berk H, Eter N, Wiedemann P, Lang GE, Rehak M, Wolf A, Bertelmann T, Hattenbach LO; COMRADE-C Study Group. Hoerauf H, et al. Among authors: rehak m. Am J Ophthalmol. 2016 Sep;169:258-267. doi: 10.1016/j.ajo.2016.04.020. Epub 2016 May 7. Am J Ophthalmol. 2016. PMID: 27163237 Clinical Trial.
Reply.
Hoerauf H, Feltgen N, Weiss C, Paulus EM, Schmitz-Valckenberg S, Pielen A, Puri P, Berk H, Eter N, Wiedemann P, Lang GE, Rehak M, Wolf A, Bertelmann T, Hattenbach LO. Hoerauf H, et al. Among authors: rehak m. Am J Ophthalmol. 2016 Sep;169:292-293. doi: 10.1016/j.ajo.2016.06.016. Epub 2016 Jul 9. Am J Ophthalmol. 2016. PMID: 27401725 No abstract available.
143 results